Cambodia’s healthcare system is undergoing rapid modernization. Rising cancer incidence, expanding hospital infrastructure, greater patient awareness, and stronger regulatory expectations are reshaping pharmaceutical procurement. In this environment, the choice of manufacturing partner matters more than ever. Selecting an EU GMP oncology manufacturer such as Aliyan Pharmaceuticals has moved from a preferred option to a strategic